Combined modality treatment of Hodgkin’s disease confined to lymph nodes. Results 14 years later
Although extended field radiotherapy can cure most patients with Hodgkin’s disease confined to lymph nodes, a significant number of potentially curable patients given radiotherapy alone relapse and ultimately die of their disease. Combination chemotherapy produces complete remission and prolonged disease-free survival in the majority of patients with advanced disease [1–4]. This study was initially designed following a pilot investigation which demonstrated the feasibility of a combined modality approach to the treatment of early Hodgkin’s disease, confined to lymph nodes [5, 6]. We are reporting 14 years of follow-up data from this study , begun at the Baltimore Cancer Research Center of the NCI (now the University of Maryland Cancer Center).
KeywordsHerpes Zoster Small Cell Carcinoma Constrictive Pericarditis Combine Modality Treatment Stage IlIA
Unable to display preview. Download preview PDF.
- 15.Schlossberger NM and Wiernik PH (1980). The pulmonary function of post-therapy Hodgkin’s disease patients. Proc Amer Assoc Cancer Res and Amer Soc Clin Oncol 21: 468.Google Scholar
- 19.O’Dwyer PJ, Wiernik PH, Stewart MB, and Slawson RG (1985). Treatment of early stage Hodgkin’s disease: A randomized trial of radiotherapy plus chemotherapy versus chemotherapy alone. In: Cavalli F, Bonadonna G, and Rozencweig M (Eds). Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances, pp 329–336. Boston: Martinus Nijhoff.Google Scholar